missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human VAC14 (aa 400-540) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (89%), Rat (89%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-55685 (PA5-55685. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Vac14 a putative cytoskeletal interacting protein; mutation of gene may be associated with lethal communicating hydrocephalus with perinatal onset.
Specifications
Specifications
| Accession Number | Q08AM6 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 55697 |
| Name | Human VAC14 (aa 400-540) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AA959718; ArPIKfyve; BC032215; D8Wsu151e; ingls; Protein VAC14 homolog; Ta x 1 (human T-cell leukemia virus type I) binding protein 1; Ta x 1 (human T-cell leukemia virus type I) binding protein 2; ta x 1-binding protein 2; TA x 1 BP2; TRX; Vac14; Vac14 homolog; Vac14 homolog (S. cerevisiae); Vac14, PIKFYVE complex component; vacuole 14 protein; vacuole morphology 14 |
| Common Name | VAC14 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction